BANK OF AMERICA CORP /DE/ - DENALI THERAPEUTICS INC ownership

DENALI THERAPEUTICS INC's ticker is DNLI and the CUSIP is 24823R105. A total of 186 filers reported holding DENALI THERAPEUTICS INC in Q2 2022. The put-call ratio across all filers is 0.37 and the average weighting 0.3%.

Quarter-by-quarter ownership
BANK OF AMERICA CORP /DE/ ownership history of DENALI THERAPEUTICS INC
ValueSharesWeighting
Q3 2023$6,102,230
-23.5%
295,794
+9.5%
0.00%0.0%
Q2 2023$7,974,929
-17.6%
270,245
-35.6%
0.00%0.0%
Q1 2023$9,673,021
+3.9%
419,836
+25.4%
0.00%0.0%
Q4 2022$9,310,009
+37.8%
334,772
+52.0%
0.00%0.0%
Q3 2022$6,758,000
+92.9%
220,217
+85.0%
0.00%
Q2 2022$3,504,000
-54.9%
119,067
-50.6%
0.00%
-100.0%
Q1 2022$7,761,000
+35.0%
241,235
+87.1%
0.00%0.0%
Q4 2021$5,751,000
+46.5%
128,948
+65.6%
0.00%
Q3 2021$3,925,000
-21.5%
77,846
+22.1%
0.00%
-100.0%
Q2 2021$5,000,000
+69.1%
63,752
+23.1%
0.00%
Q1 2021$2,956,000
-25.4%
51,771
+9.5%
0.00%
-100.0%
Q4 2020$3,961,000
+279.8%
47,294
+62.5%
0.00%
Q3 2020$1,043,000
+28.9%
29,103
-12.9%
0.00%
Q2 2020$809,000
+67.5%
33,410
+21.0%
0.00%
Q1 2020$483,000
+10.8%
27,609
+10.2%
0.00%
Q4 2019$436,000
-34.7%
25,044
-42.6%
0.00%
Q3 2019$668,000
-60.1%
43,624
-45.9%
0.00%
Q2 2019$1,675,000
-11.9%
80,664
-1.5%
0.00%
Q1 2019$1,901,000
+429.5%
81,862
+371.4%
0.00%
Q4 2018$359,000
+184.9%
17,367
+200.1%
0.00%
Q3 2018$126,000
+96.9%
5,787
+37.0%
0.00%
Q2 2018$64,000
+113.3%
4,224
+184.6%
0.00%
Q1 2018$30,000
+650.0%
1,484
+422.5%
0.00%
Q4 2017$4,0002840.00%
Other shareholders
DENALI THERAPEUTICS INC shareholders Q2 2022
NameSharesValueWeighting ↓
Crestline Management, LP 7,705,039$343,645,00025.68%
Casdin Capital, LLC 1,500,000$66,900,0001.89%
Flagship Pioneering Inc. 2,619,968$116,851,0001.81%
SECTORAL ASSET MANAGEMENT INC 189,600$8,456,0001.27%
Integral Health Asset Management, LLC 100,000$4,460,0001.23%
Temasek Holdings (Private) Ltd 5,369,487$239,479,0000.86%
Goldstream Capital Management Ltd 78,418$3,497,0000.86%
Yiheng Capital Management, L.P. 335,184$14,949,0000.76%
GILDER GAGNON HOWE & CO LLC 2,900,114$129,345,0000.74%
Artal Group S.A. 600,000$26,760,0000.73%
View complete list of DENALI THERAPEUTICS INC shareholders